
|Articles|September 11, 2015
Priority Review to Multiple Myeloma, Lung Cancer Drugs Highlights Specialty Pharmacy Week in Review
Author(s)Davy James, Managing Editor
Top stories of the week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/priority-review-to-multiple-myeloma-lung-cancer-dr" target="_blank">View the story "Priority Review to Multiple Myeloma, Lung Cancer Drugs Highlights Specialty Pharmacy Week in Review" on Storify</a>]
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists at the Forefront: Initiating, Monitoring, and Identifying Candidates for VMAT2 Therapy
2
FDA Accepts NDA for AD109 for Treatment of Adults With Obstructive Sleep Apnea
3
Investigational mRNA Flu Vaccine Broadens Antibody Defenses, Sustains Immune "Training Hub" Longer Than Standard Shot
4
Workforce Preparation for Fall Immunization Season Starts Now
5






































































































